A Dark Vector Cognition product

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

59K characters. Original on sec.gov ·

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The 21 tables in Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

The following discussion and analysis of our financial condition as of September 30, 2026, and results of operations for the three and nine months ended September 30, 2026 and 2025, should be read in conjunction with the unaudited consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes in our 2025 Annual Report on Form 10-K for the year ended December 31, 2025. The discussion includes references to non-GAAP financial measures, such as adjusted gross margin, which supplement our GAAP results by providing additional insight into our financial and operational performance. For definitions and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures, refer to “Non-GAAP Measures” within this Quarterly Report on Form 10-Q. This discussion also contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in such forward-looking statements.

Overview

Axon is a technology company that provides integrated hardware and software solutions. Our products and services allow customers across the public and private sector to capture and use critical data to support fully-connected operational workflows. Our trusted network seamlessly integrates software and hardware with a range of connected devices, including TASER energy devices, cameras and sensors, drones and robotics, cloud-based evidence management, records management, real-time operations software, critical incident and emergency response systems, immersive training, and productivity tools – all enhanced by artificial intelligence.

Our revenues for the three months ended September 30, 2026 were $908.6 million, an increase of $197.9 million, or 27.8%, from the three months ended September 30, 2025. We had income from operations of $42.1 million, compared to loss from operations of $2.1 million for the same period in the prior year. Gross margin dollars increased $87.6 million and decreased as a percentage of revenue to 56.7% from 60.1% compared to the three months ended September 30, 2025. Adjusted gross margin decreased to 59.2% for the three months ended September 30, 2026 compared to 62.7% for the same period in the prior year. The decrease in gross margin and adjusted gross margin was primarily driven by an increased mix of counter-drone equipment, scaling of new product offerings and higher memory costs. Operating expenses increased by $43.4 million, primarily reflecting increased headcount and investments in AI and other initiatives to support business growth. Net income of $57.0 million included a $21.9 million tax provision, income from strategic investments, net, of $64.1 million, and an unrealized loss of $4.4 million related to our marketable securities. Net loss of $2.2 million for the three months ended September 30, 2025 included a $17.9 million tax provision, net realized and unrealized gains of $14.6 million related to our strategic investments, and a net realized and unrealized gain of $8.3 million related to our marketable securities.

Our revenues for the nine months ended September 30, 2026 were $2.6 billion, an increase of $637.5 million, or 32.2%, from the nine months ended September 30, 2025. We had income from operations of $118.1 million, compared to loss from operations of $12.0 million for the same period in the prior year. Gross margin dollars increased $341.9 million and decreased as a percentage of revenue to 58.7% from 60.4% compared to the nine months ended September 30, 2025. Adjusted gross margin decreased to 61.2% for the nine months ended September 30, 2026 compared to 63.2% for the same period in the prior year. The decrease in gross margin and adjusted gross margin was primarily due to a higher mix of professional services revenue, scaling of new product offerings and higher memory costs, partially offset by tariff refunds received during the nine months ended September 30, 2026. Operating expenses increased by $211.8 million, primarily reflecting increased headcount and investments in AI and other initiatives to support business growth. Net income of $255.7 million included net realized and unrealized gains of $266.4 million related to our strategic investments and a $56.1 million tax provision, partially offset by a net realized and unrealized loss of $8.8 million related to our marketable securities. Net income of $121.9 million for the nine months ended September 30, 2025 included net realized and unrealized gains of $180.6 million related to our strategic investments and a $36.7 million tax benefit, partially offset by a net realized and unrealized loss of $46.0 million related to our marketable securities and inducement expense of $28.7 million associated with the early repurchase of a portion of our 2027 Notes.

On February 20, 2026, the Supreme Court determined that tariffs imposed under the International Emergency Economic Powers Act (“IEEPA”) were unauthorized. During the three months ended June 30, 2026, we received $47.4 million in refunds. Of this amount, $18.1 million had been previously expensed in 2025 to cost of sales and the remaining is associated with amounts primarily classified as inventory and property and equipment, net, for which the majority would have been expensed in the current year. There were no material changes related to tariff refunds during the three months ended September 30, 2026.

Results of Operations

Three Months Ended September 30, 2026 Compared to the Three Months Ended September 30, 2025

The following table presents data from our consolidated statements of operations as well as the percentage relationship to total net sales (dollars in thousands):

Three Months Ended September 30,
20262025
Net sales from products$471,52451.9%$405,39957.0%
Net sales from services437,03048.1305,24243.0
Net sales908,554100.0710,641100.0
Cost of product sales268,62929.6203,17328.6
Cost of service sales124,94713.780,12011.3
Cost of sales393,57643.3283,29339.9
Gross margin514,97856.7427,34860.1
Operating expenses:
Selling, general and administrative280,49630.9252,80335.6
Research and development192,40221.2176,67424.8
Total operating expenses472,89852.1429,47760.4
Income (loss) from operations42,0804.6(2,129)(0.3)
Interest income5,6570.623,9413.4
Interest expense(28,337)(3.1)(28,912)(4.1)
Other income, net59,5206.622,8033.2
Income before provision for income taxes78,9208.715,7032.2
Provision for income taxes21,9142.417,8892.5
Net income (loss)$57,0066.3%$(2,186)(0.3)%

The following table presents our revenues disaggregated by geography (dollars in thousands):

Three Months Ended September 30,
20262025
United States$772,02685%$593,93984%
Other countries136,52815116,70216
Total$908,554100%$710,641100%

International revenue increased compared to the prior year September 30, 2025 comparative period, primarily driven by increased sales in our EMEA region.

Net Sales

Net sales by product line were as follows (dollars in thousands):

Three Months Ended September 30,Dollar ChangePercent Change
20262025
Connected Devices segment:
TASER (1)$233,04025.6%$237,95033.5%$(4,910)(2.1)%
Personal Sensors (2)113,53212.5106,67715.06,8556.4
Platform Solutions (3)124,95213.860,7728.564,180105.6
Total Connected Devices segment471,52451.9405,39957.066,12516.3
Total Software and Services segment437,03048.1305,24243.0131,78843.2
Total net sales$908,554100.0%$710,641100.0%$197,91327.8%

(1)'TASER' includes TASER devices, cartridges and related extended warranties.

(2)'Personal Sensors' primarily includes body cameras and accessories, signal sidearm, and related extended warranties.

(3)'Platform Solutions' primarily includes fleet in-car video, interview room, fixed cameras, drones and counter-drone equipment, virtual reality training hardware, and related extended warranties.

Net sales for the Connected Devices segment increased 16.3% for the three months ended September 30, 2026 compared to the three months ended September 30, 2025. The decrease of $4.9 million in TASER is primarily driven by legacy TASER volume, partially offset by higher TASER 10 cartridge volume. Personal Sensors increased $6.9 million primarily attributable to continued adoption of our newest body camera, AB4, and higher warranty revenue from more devices in the field. The $64.2 million increase in Platform Solutions is primarily driven by higher volume for counter-drone equipment, which may be subject to increased volatility driven by the timing of large customer contracts.

Net sales for the Software and Services segment increased 43.2% for the three months ended September 30, 2026 compared to the three months ended September 30, 2025. The increase in the aggregate number of users and growing adoption of our premium solutions by existing customers drove the majority of the increase of $131.8 million.

Gross Margin

As a percentage of net sales, gross margin for the Connected Devices segment decreased to 43.0% from 49.9% for the three months ended September 30, 2026 and 2025, respectively. Adjusted gross margin for the Connected Devices segment was 44.6% for the three months ended September 30, 2026, compared to 52.1% for the three months ended September 30, 2025. The decrease in gross margin and adjusted gross margin was primarily driven by an increased mix of counter-drone equipment and higher memory costs.

As a percentage of net sales, gross margin for the Software and Services segment decreased to 71.4% from 73.8% for the three months ended September 30, 2026 and 2025, respectively. Adjusted gross margin for the Software and Services segment decreased to 75.0% for the three months ended September 30, 2026, compared to 76.8% for the three months ended September 30, 2025. The decrease in gross margin and adjusted gross margin was primarily driven by the scaling of new product offerings and a higher mix of professional services revenue.

Selling, General and Administrative Expenses

SG&A expenses were as follows (dollars in thousands):

Three Months Ended September 30,Dollar ChangePercent Change
20262025
Total selling, general and administrative expenses$280,496$252,803$27,69311.0%
As a percentage of net sales30.9%35.6%

Salaries, benefits and bonus expense increased $7.3 million in comparison to the prior year September 30, 2025 comparable period, primarily attributable to an increase in headcount.

Sales and marketing expense increased $7.1 million in comparison to the prior year September 30, 2025 comparable period, primarily attributable to increased commissions.

Other SG&A expenses increased $13.3 million in comparison to the prior year September 30, 2025 comparable period, primarily driven by increased technology license expenses of $4.7 million as a result of the continued adoption of AI initiatives, as well as increased stock-based compensation expenses of $3.2 million which were partially attributable to an increase in headcount.

Research and Development Expenses

R&D expenses were as follows (dollars in thousands):

Three Months Ended September 30,Dollar ChangePercent Change
20262025
Total research and development expenses$192,402$176,674$15,7288.9%
As a percentage of net sales21.2%24.8%

Salaries, benefits and bonus expense increased $6.5 million in comparison to the prior year September 30, 2025 comparable period, which was primarily attributable to an increase in headcount.

Other R&D expenses increased $9.2 million in comparison to the prior year September 30, 2025 comparable period, primarily driven by increased stock-based compensation expenses of $6.8 million which were partially attributable to an increase in headcount.

Interest Income (Expense), Net

Interest income (expense), net, was as follows (in thousands):

Three Months Ended September 30,
20262025
Interest income (1)$5,657$23,941
Interest expense(28,337)(28,912)
Total interest expense, net$(22,680)$(4,971)

(1)Interest income decreased primarily due to lower average balances of short-term investments compared to the prior year September 30, 2025 comparable period.

Other Income, Net

Other income, net, was as follows (in thousands):

Three Months Ended September 30,
20262025
Income from strategic investments, net (1)$64,117$14,618
Realized and unrealized gain (loss) on marketable securities, net (2)(4,375)8,275
Loss on foreign currency transactions, net(317)(160)
Other, net9570
Other income, net$59,520$22,803

(1)Reflects the net realized and unrealized income (loss) associated with our strategic investments, during the three months ended September 30, 2026 and 2025, as discussed within Note 6.

(2)Reflects the net realized and unrealized gain (loss) on marketable securities, during the three months ended September 30, 2026 and 2025, as discussed within Note 3.

Provision for Income Taxes

The effective tax rate was 27.8% for the three months ended September 30, 2026, compared to 113.9% for the three months ended September 30, 2025. The decrease in effective tax rate for the quarter was primarily driven by higher pre-tax book income which reduced the relative impact of permanent and discrete tax items, along with a greater benefit from R&D tax credits, partially offset by a lower net tax benefit from stock-based compensation.

Provision for income taxes and effective tax rates were as follows (dollars in thousands):

Three Months Ended September 30,
20262025Change
Income before provision for income taxes$78,920$15,703$63,217
Provision for income taxes$21,914$17,889$4,025
Effective tax rate27.8%113.9%

Net Income

We recorded net income of $57.0 million for the three months ended September 30, 2026 compared to net loss of $2.2 million for the three months ended September 30, 2025. Net income (loss) per basic share was $0.70 for the three months ended September 30, 2026 compared to $(0.03) for the three months ended September 30, 2025. Net income (loss) per diluted share was $0.68 for the three months ended September 30, 2026 compared to $(0.03) for the three months ended September 30, 2025.

Nine Months Ended September 30, 2026 Compared to the Nine Months Ended September 30, 2025

The following table presents data from our consolidated statements of operations as well as the percentage relationship to total net sales (dollars in thousands):

Nine Months Ended September 30,
20262025
Net sales from products$1,430,89854.6%$1,122,65556.6%
Net sales from services1,189,39045.4860,15743.4
Net sales2,620,288100.01,982,812100.0
Cost of product sales744,64628.4566,86128.6
Cost of service sales336,93112.9219,12111.0
Cost of sales1,081,57741.3785,98239.6
Gross margin1,538,71158.71,196,83060.4
Operating expenses:
Selling, general and administrative830,57131.7718,52436.2
Research and development590,03922.5490,26424.8
Total operating expenses1,420,61054.21,208,78861.0
Income (loss) from operations118,1014.5(11,958)(0.6)
Interest income23,0830.957,7982.9
Interest expense(85,081)(3.2)(65,419)(3.3)
Other income, net255,7229.7104,7905.3
Income before provision for income taxes311,82511.985,2114.3
Provision for (benefit from) income taxes56,0802.1(36,700)(1.8)
Net income$255,7459.8%$121,9116.1%

The following table presents our revenues disaggregated by geography (dollars in thousands):

Nine Months Ended September 30,
20262025
United States$2,160,86082%$1,660,69584%
Other countries459,42818322,11716
Total$2,620,288100%$1,982,812100%

International revenue increased compared to the prior year September 30, 2025 comparative period, primarily driven by increased sales in our EMEA region.

Net Sales

Net sales by product line were as follows (dollars in thousands):

Nine Months Ended September 30,Dollar ChangePercent Change
20262025
Connected Devices segment:
TASER (1)$727,21427.8%$649,67932.8%$77,53511.9%
Personal Sensors (2)317,67512.1287,90114.529,77410.3
Platform Solutions (3)386,00914.7185,0759.3200,934108.6
Total Connected Devices segment1,430,89854.61,122,65556.6308,24327.5
Total Software and Services segment1,189,39045.4860,15743.4329,23338.3
Total net sales$2,620,288100.0%$1,982,812100.0%$637,47632.2%

(1)'TASER' includes TASER devices, cartridges and related extended warranties.

(2)'Personal Sensors' primarily includes body cameras and accessories, signal sidearm, and related extended warranties.

(3)'Platform Solutions' primarily includes fleet in-car video, interview room, fixed cameras, drones and counter-drone equipment, virtual reality training hardware, and related extended warranties.

Net sales for the Connected Devices segment increased 27.5% for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025. The increase of $77.5 million in TASER is primarily driven by higher TASER 10 device and cartridge volume. Personal Sensors increased $29.8 million primarily attributable to continued adoption of our newest body camera, AB4, and higher warranty revenue from more devices in the field. The $200.9 million increase in Platform Solutions is primarily driven by higher volume of counter-drone equipment, which may be subject to increased volatility driven by the timing of large customer contracts.

Net sales for the Software and Services segment increased 38.3% for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025. The increase in the aggregate number of users and growing adoption of our premium add-on features by existing customers drove the majority of the increase of $329.2 million.

Gross Margin

As a percentage of net sales, gross margin for the Connected Devices segment decreased to 48.0% from 49.5% for the nine months ended September 30, 2026 and 2025, respectively. Adjusted gross margin for the Connected Devices segment was 49.6% for the nine months ended September 30, 2026, compared to 52.0% for the nine months ended September 30, 2025. The decrease in gross margin and adjusted gross margin was primarily driven by an increased mix of counter-drone equipment and higher memory costs, partially offset by tariff refunds.

As a percentage of net sales, gross margin for the Software and Services segment decreased to 71.7% from 74.5% for the nine months ended September 30, 2026 and 2025, respectively. Adjusted gross margin for the Software and Services segment decreased to 75.3% for the nine months ended September 30, 2026, compared to 77.8% for the nine months ended September 30, 2025. The decrease in gross margin and adjusted gross margin was primarily driven by a higher mix of professional services revenue and scaling of new product offerings.

Selling, General and Administrative Expenses

SG&A expenses were as follows (dollars in thousands):

Nine Months Ended September 30,Dollar ChangePercent Change
20262025
Total selling, general and administrative expenses$830,571$718,524$112,04715.6%
As a percentage of net sales31.7%36.2%

Salaries, benefits and bonus expense increased $30.1 million in comparison to the prior year September 30, 2025 comparable period, primarily attributable to an increase in headcount.

Sales and marketing expense increased $26.2 million in comparison to the prior year September 30, 2025 comparable period, primarily attributable to increased commissions.

Other SG&A expenses increased $55.7 million in comparison to the prior year September 30, 2025 comparable period, primarily attributable to increased advisory expenses of $18.6 million, $11.2 million of increased technology license expenses as a result of the continued adoption of AI initiatives, and increased travel expenses of $10.0 million.

Research and Development Expenses

R&D expenses were as follows (dollars in thousands):

Nine Months Ended September 30,Dollar ChangePercent Change
20262025
Total research and development expenses$590,039$490,264$99,77520.4%
As a percentage of net sales22.5%24.8%

Salaries, benefits and bonus expense increased $47.9 million in comparison to the prior year September 30, 2025 comparable period, which was primarily attributable to an increase in headcount.

Stock-based compensation expense increased $15.4 million in comparison to the prior year September 30, 2025 comparable period, partially attributable to increased headcount.

Other R&D expenses increased $36.5 million in comparison to the prior year September 30, 2025 comparable period, primarily driven by $12.4 million of increased technology license expenses as a result of the continued adoption of AI initiatives and $10.0 million of increased engineering expenses.

Interest Income (Expense), Net

Interest income (expense), net, was as follows (in thousands):

Nine Months Ended September 30,
20262025
Interest income (1)$23,083$57,798
Interest expense(85,081)(65,419)
Total interest expense, net$(61,998)$(7,621)

(1)Interest income decreased primarily due to lower average balances of short-term investments compared to the prior year September 30, 2025 comparable period.

Other Income, Net

Other income, net, was as follows (in thousands):

Nine Months Ended September 30,
20262025
Income from strategic investments, net (1)$266,426$180,642
Realized and unrealized loss on marketable securities, net (2)(8,811)(45,994)
Loss on foreign currency transactions, net(1,906)(1,376)
Induced conversion of convertible debt—(28,666)
Other, net13184
Other income, net$255,722$104,790

(1)Reflects the net realized and unrealized income associated with our strategic investments, during the nine months ended September 30, 2026 and 2025, as discussed within Note 6.

(2)Reflects the net realized and unrealized loss on marketable securities, during the nine months ended September 30, 2026 and 2025, as discussed within Note 3.

Provision for Income Taxes

The effective tax rate was 18.0% for the nine months ended September 30, 2026, compared to (43.1)% for the nine months ended September 30, 2025. The increase in effective tax rate for the nine months ended September 30, 2026 was primarily driven by higher pre-tax book income which reduced the relative impact of permanent and discrete items, a less favorable net tax benefit from stock-based compensation, and higher state income taxes, partially offset by more favorable R&D tax credits and the favorable impact of a gain on an investment transaction not recognized for tax purposes.

Provision for (benefit from) income taxes and effective tax rates were as follows (dollars in thousands):

Nine Months Ended September 30,
20262025Change
Income before provision for income taxes$311,825$85,211$226,614
Provision for (benefit from) income taxes$56,080$(36,700)$92,780
Effective tax rate18.0%(43.1)%

Net Income

We recorded net income of $255.7 million for the nine months ended September 30, 2026 compared to net income of $121.9 million for the nine months ended September 30, 2025. Net income per basic share was $3.17 for the nine months ended September 30, 2026 compared to $1.57 for the nine months ended September 30, 2025. Net income per diluted share was $3.08 for the nine months ended September 30, 2026 compared to $1.48 for the nine months ended September 30, 2025.

Non-GAAP Measures

We utilize certain non-GAAP financial measures such as EBITDA, adjusted EBITDA, and adjusted gross margin as defined below to enhance understanding of our financial results and related measures. We have adjusted for expenses that we believe are not indicative of our core operating results. Our management uses these non-GAAP financial measures in evaluating our operating performance. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance, and when planning and forecasting our future periods. A reconciliation of GAAP to the non-GAAP financial measures is presented below.

Beginning in the quarterly period ended March 31, 2026, we updated the calculation of Adjusted EBITDA to exclude all components of other income (loss), net – primarily resulting in incremental adjustments for foreign currency exchange gains and losses, net and fees incurred related to our Credit Agreement, as we do not consider these adjustments to be representative of our core operating results. For all comparable prior periods presented, our adjustment for other income (loss), net does not include the above incremental items, as the impact of this change on historical periods was determined to be de minimis. Accordingly, other income (loss), net for all comparable prior periods has not been recast and solely reflects adjustment for the impacts of net realized and unrealized gains on strategic investments and marketable securities, net realized gains on previously held minority interests acquired in business combinations and debt inducement expense.

Furthermore, beginning in the quarterly period ended June 30, 2026, we updated the calculation of Adjusted EBITDA and Adjusted Gross Margin to exclude additional jurisdiction-specific compensation-related taxes incurred as a direct result of Employee XSP vesting events. This update expands upon our existing adjustment, which was historically limited to payroll taxes related to Employee XSP vesting events. For all comparable prior periods presented, our adjustment does not include any incremental jurisdiction-specific compensation-related taxes, as the impact of this change on historical periods was determined to be de minimis. Accordingly, compensation taxes related to Employee XSP vesting for all comparable prior periods has not been recast and solely reflects adjustment for payroll taxes incurred.

  • EBITDA (most comparable GAAP measure: Net income) – Earnings before interest expense, investment interest income, income taxes, depreciation and amortization.

  • Adjusted EBITDA (most comparable GAAP measure: Net income) – Earnings before interest expense; investment interest income; income taxes; depreciation; amortization; all components of other income (loss), net, which is primarily comprised of fair value adjustments and income or losses related to strategic investments and marketable securities, debt inducement expense associated with the early repurchase of a portion of our 2027 Notes, foreign currency exchange gains and losses, net, and fees incurred related to our Credit Agreement; noncash stock-based compensation expense; transaction and integration costs related to strategic investments and acquisitions, including the change in fair value of contingent consideration arrangements and certain compensation costs directly related to employee integration activities; non-recurring severance costs, including employee cash payments, equity, and related benefits; costs (or subsequent recoveries of prior costs) related to certain legal or regulatory matters we consider outside of our core operating activities; mark-to-market adjustments on our non-qualified deferred compensation liabilities; compensation taxes related to Employee XSP vesting; losses incurred as a result of the disposal, abandonment, and impairment of property, equipment, and intangible assets, and inventory step-up amortization related to acquisitions.

  • Adjusted gross margin (most comparable GAAP measure: Gross margin) – Gross margin before noncash stock-based compensation expense; compensation taxes related to Employee XSP vesting; amortization of acquired intangible assets; non-recurring severance costs, including employee cash payments, equity, and related benefits; and inventory step-up amortization related to acquisitions.

Although these non-GAAP financial measures are not consistent with GAAP, management believes investors will benefit by referring to these non-GAAP financial measures when assessing our operating results, as well as when forecasting and analyzing future periods. However, management recognizes that:

  • these non-GAAP financial measures are limited in their usefulness and should be considered only as a supplement to our GAAP financial measures;

  • these non-GAAP financial measures should not be considered in isolation from, or as a substitute for, our GAAP financial measures;

  • these non-GAAP financial measures should not be considered to be superior to our GAAP financial measures; and

  • these non-GAAP financial measures were not prepared in accordance with GAAP and investors should not assume that the non-GAAP financial measures presented in this Quarterly Report on Form 10-Q were prepared under a comprehensive set of rules or principles.

EBITDA and adjusted EBITDA reconcile to net income as follows (in thousands):

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Net income (loss)$57,006$(2,186)$255,745$121,911
Depreciation and amortization32,35721,31093,31859,829
Interest expense28,33728,91285,08165,419
Investment interest income(5,657)(23,941)(23,083)(57,798)
Provision for (benefit from) income taxes21,91417,88956,080(36,700)
EBITDA$133,957$41,984$467,141$152,661
Non-GAAP adjustments:
Other income, net(59,520)(22,893)(255,722)(105,981)
Stock-based compensation expense151,312146,152429,317425,635
Transaction and integration costs related to strategic investments and acquisitions (1)7,2424,77418,2909,731
Compensation taxes related to Employee XSP vesting185—9,7179,782
Litigation and regulatory costs2,3805,4905,6008,313
Severance costs (1)——2,730—
Non-qualified deferred compensation liability adjustments—1,0732,1372,634
Loss on disposal, abandonment, and impairment of property, equipment and intangible assets, net104430104430
Inventory step-up amortization———607
Adjusted EBITDA$235,660$177,010$679,314$503,812

(1)For the three and nine months ended September 30, 2026, non-recurring compensation costs were $5.5 million and $8.2 million, respectively. These costs consisted of stock-based compensation, cash payments and employee benefits, the majority of which derived from acquisition integration activities.

Adjusted gross margin reconciles to gross margin as follows (in thousands):

Three Months Ended September 30,
20262025
Connected DevicesSoftware and ServicesTotalConnected DevicesSoftware and ServicesTotal
Gross margin$202,895$312,083$514,978$202,226$225,122$427,348
Stock-based compensation expense5,8507,11012,9607,5845,11912,703
Amortization of acquired intangible assets1,7308,57210,3021,3184,0815,399
Adjusted gross margin$210,475$327,765$538,240$211,128$234,322$445,450
Gross margin %43.0%71.4%56.7%49.9%73.8%60.1%
Adjusted gross margin %44.6%75.0%59.2%52.1%76.8%62.7%
Nine Months Ended September 30,
20262025
Connected DevicesSoftware and ServicesTotalConnected DevicesSoftware and ServicesTotal
Gross margin$686,252$852,459$1,538,711$555,794$641,036$1,196,830
Stock-based compensation expense17,14117,66334,80422,64315,50838,151
Amortization of acquired intangible assets5,18924,38029,5693,98811,56015,548
Compensation taxes related to Employee XSP vesting4266331,0596348541,488
Severance costs (1)12120141———
Inventory step-up amortization———607—607
Adjusted gross margin$709,129$895,155$1,604,284$583,666$668,958$1,252,624
Gross margin %48.0%71.7%58.7%49.5%74.5%60.4%
Adjusted gross margin %49.6%75.3%61.2%52.0%77.8%63.2%

(1)For the nine months ended September 30, 2026, non-recurring severance costs recorded to cost of service and product sales consisted of stock-based compensation, cash payments and employee benefits.

Liquidity and Capital Resources

Summary

September 30, 2026December 31, 2025Dollar Change
Cash and cash equivalents$1,458,817$1,201,147$257,670
Available-for-sale investments181,587505,417(323,830)
Total$1,640,404$1,706,564$(66,160)

Our most significant source of liquidity typically includes funds generated by operating activities and available cash and cash equivalents and short-term investments. As of September 30, 2026, we had $1.5 billion of cash and cash equivalents, an increase of $257.7 million from December 31, 2025. As of September 30, 2026, we had $181.6 million of available-for-sale investments, a decrease of $323.8 million from December 31, 2025, primarily due to sales and maturities of available-for-sale securities during the period. Refer to Note 3 in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional details.

In addition, our Credit Agreement is available for additional working capital needs or investment opportunities. As of September 30, 2026, we had letters of credit outstanding of approximately $9.1 million under the facility and available borrowing of $490.9 million. Refer to Note 8 in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional details.

As of September 30, 2026, we have an aggregate of $1.75 billion of Senior Notes and $1.15 billion of 2031 Notes outstanding. As of September 30, 2026, none of our subsidiaries guarantee the Senior Notes or 2031 Notes. Our non-guarantor subsidiaries accounted for approximately 19% of our total revenue for the nine months ended September 30, 2026, and approximately 17% and 6% of our total consolidated assets and liabilities (excluding the effect of intercompany transactions), respectively, as of September 30, 2026. Refer to Note 8 in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional details of the 2031 Notes.

On November 5, 2026, we entered into agreements to make incremental minority investments of up to $1.2 billion in Skydio. We expect the investments to be settled with up to approximately $720.0 million in cash and the remainder in shares of the Company’s common stock, with the final mix subject to the results of a tender offer and secondary purchases that are expected to close in the fourth quarter of 2026 and first quarter of 2027. We paid approximately $127.5 million in cash at the closing of the Company’s primary investment on November 5, 2026, and the remaining cash consideration will be funded utilizing our available cash on hand. Refer to Note 15 in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional details.

We believe we have access to additional financing. However, there is no assurance that such funding will be available on terms acceptable to us, or at all. We believe that our sources of funding will be sufficient to satisfy our currently anticipated cash requirements, including capital expenditures, working capital requirements, potential acquisitions or investments, income and payroll tax payments for net-settled stock awards, and other liquidity requirements through at least the next 12 months.

Going forward, we expect to continue to be an opportunistic issuer of debt securities and may issue new debt securities from time to time to fund our growth or refinance future debt maturities, among other things. In addition, from time to time, we may acquire our debt securities through open market purchases, redemptions, privately negotiated transactions, tender offers, exchange offers or otherwise, upon such terms and at such prices as we may from time to time determine, for cash or other consideration.

Cash Flows

The following table summarizes our cash flows from operating, investing and financing activities (in thousands):

Nine Months Ended September 30,Dollar Change
20262025
Operating activities$8,247$(5,896)$14,143
Investing activities(618,294)(498,490)(119,804)
Financing activities870,4681,468,024(597,556)
Effect of exchange rate changes on cash and cash equivalents(1,786)5,741(7,527)
Net increase (decrease) in cash and cash equivalents and restricted cash$258,635$969,379$(710,744)

Operating activities

Net cash provided by operating activities was $8.2 million for the nine months ended September 30, 2026 compared to net cash used in operating activities of $5.9 million for the nine months ended September 30, 2025.

The net operating cash inflow for the nine months ended September 30, 2026 includes net income of $255.7 million, an increase of $133.8 million when compared to the same period in the prior year. Primary drivers of the non-cash adjustments to net income during the nine months ended September 30, 2026 include $435.1 million of stock-based compensation expense for employee equity programs, $96.1 million of depreciation and amortization, and $36.1 million for deferred income taxes, partially offset by $257.6 million in fair value adjustments for net realized and unrealized gains and losses on our strategic investments and marketable securities. The realized and unrealized gains on our strategic investments were primarily driven by observable price changes for one of our investees. The deferred income taxes were primarily driven by investment-related gains and the amortization of previously capitalized R&D, partially offset by unvested stock-based compensation.

The change in operating assets and liabilities during the nine months ended September 30, 2026, when compared to the same period in the prior year, includes an increase in inventory purchases of $180.0 million, partially offset by $64.1 million of accounts payable, accrued and other liabilities. The increased inventory activity was primarily driven by advanced purchases of materials for TASER 10 CEDs and counter-drone equipment. Net of deferred revenue, our increase in receivables and contract assets of $19.2 million was driven by our increased sales, as well as the timing of invoicing and cash collections.

Investing activities

Net cash used in investing activities was $618.3 million for the nine months ended September 30, 2026 compared to $498.5 million for the nine months ended September 30, 2025. The net investing cash outflow is primarily driven by $552.0 million for business combination activity which is substantially all related to the Carbyne acquisition, $490.7 million for investment purchases which include $309.2 million of strategic investment purchases, and $82.8 million for purchases of property and equipment. The cash outflow was partially offset by $509.4 million of proceeds from calls, maturities and sales of available-for-sale and marketable securities investments. The increase in net cash outflow compared to the prior period is primarily driven by the acquisition of Carbyne, partially offset by decreased net purchases of available-for-sale and marketable securities and strategic investments.

Financing activities

Net cash provided by financing activities was $870.5 million for the nine months ended September 30, 2026 compared to $1.5 billion for the nine months ended September 30, 2025. The financing cash inflow in the current period was primarily driven by gross proceeds from the 2031 Notes issuance of $1.15 billion and $100.3 million of net cash proceeds from our ATM equity offering program. The proceeds were partially offset by $114.9 million of capped call purchases in relation to the 2031 Notes issuance, $167.2 million of income and payroll tax payments made on behalf of employees who net-settled stock awards during the period excluding $0.1 million which was not yet remitted as of September 30, 2026, $81.1 million of principal payments related to the redemption of our 2027 Notes, and $17.3 million of transaction expenses associated with the offering and revolver modifications. Net cash provided by financing activities in the prior period primarily reflects gross proceeds of $1.8 billion from the Senior Notes issuance, partially offset by principal payments of $407.5 million related to the induced conversion of our 2027 Notes during the nine months ended September 30, 2025. The decrease in net cash inflow compared to the prior period is primarily driven by lower proceeds from debt and equity issuances and capped call premiums paid in the current period, partially offset by fewer principal payments.

Critical Accounting Estimates

Our management’s discussion and analysis of our financial condition and results of operation is based on our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances, and we evaluate our estimates and assumptions on an ongoing basis. While we do not believe that a change in these estimates is reasonably likely, there can be no assurance that our actual results will not differ from these estimates.

Our critical accounting estimates are discussed in our 2025 Annual Report on Form 10-K for the fiscal year ended December 31, 2025. There have been no significant changes to these critical accounting estimates for the nine months ended September 30, 2026.

Previous: Item 1. Financial Statements · Next: Item 3. Quantitative and Qualitative Disclosures About Market Risk